Towards broad-spectrum protection: the development and challenges of combined respiratory virus vaccines

被引:4
作者
Wang, Yang [1 ,2 ]
Wei, Xiaotong [1 ]
Liu, Yang [1 ,3 ]
Li, Shengfeng [1 ]
Pan, Weiqi [1 ,4 ]
Dai, Jun [2 ,3 ]
Yang, Zifeng [1 ,2 ,4 ]
机构
[1] Guangzhou Med Univ, Affiliated Hosp 1, Natl Clin Res Ctr Resp Dis, State Key Lab Resp Dis,Guangzhou Inst Resp Hlth, Guangzhou, Peoples R China
[2] Guangzhou Natl Lab, Guangzhou, Peoples R China
[3] Guangzhou Customs Technol Ctr, Guangzhou, Peoples R China
[4] Macau Univ Sci & Technol, Fac Innovat Engn, Resp Dis AI Lab Epidem & Med Big Data Instrument A, Macau, Peoples R China
基金
中国国家自然科学基金;
关键词
combined vaccine; SARS-CoV-2; COVID-19; influenza virus; RSV; mRNA vaccine; subunit vaccine; viral vector vaccine; MESSENGER-RNA VACCINES; SUBUNIT VACCINES; INFLUENZA; INFECTION; SARS-COV-2; ANTIBODIES; FRONTIERS; CHILDREN; DESIGN;
D O I
10.3389/fcimb.2024.1412478
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In the post-COVID-19 era, the co-circulation of respiratory viruses, including influenza, SARS-CoV-2, and respiratory syncytial virus (RSV), continues to have significant health impacts and presents ongoing public health challenges. Vaccination remains the most effective measure for preventing viral infections. To address the concurrent circulation of these respiratory viruses, extensive efforts have been dedicated to the development of combined vaccines. These vaccines utilize a range of platforms, including mRNA-based vaccines, viral vector vaccines, and subunit vaccines, providing opportunities in addressing multiple pathogens at once. This review delves into the major advancements in the field of combined vaccine research, underscoring the strategic use of various platforms to tackle the simultaneous circulation of respiratory viruses effectively.
引用
收藏
页数:10
相关论文
共 96 条
[1]  
Adams K, 2022, MMWR-MORBID MORTAL W, V71, P1589, DOI 10.15585/mmwr.mm7150a4
[2]   A phase 1, randomized, placebo-controlled study to evaluate the safety and immunogenicity of an mRNA-based RSV prefusion F protein vaccine in healthy younger and older adults [J].
Aliprantis, Antonios O. ;
Shaw, Christine A. ;
Griffin, Paul ;
Farinola, Nicholas ;
Railkar, Radha A. ;
Cao, Xin ;
Liu, Wen ;
Sachs, Jeffrey R. ;
Swenson, Christine J. ;
Lee, Heather ;
Cox, Kara S. ;
Spellman, Daniel S. ;
Winstead, Colleen J. ;
Smolenov, Igor ;
Lai, Eseng ;
Zaks, Tal ;
Espeseth, Amy S. ;
Panther, Lori .
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (05) :1248-1261
[3]   A Recombinant VSV-Based Bivalent Vaccine Effectively Protects against Both SARS-CoV-2 and Influenza A Virus Infection [J].
Ao, Zhujun ;
Ouyang, Maggie J. ;
Olukitibi, Titus A. ;
Warner, Bryce ;
Vendramelli, Robert ;
Truong, Thang ;
Meilleur, Courtney ;
Zhang, Manli ;
Kung, Sam ;
Fowke, Keith R. ;
Kobasa, Darwyn ;
Yao, Xiaojian .
JOURNAL OF VIROLOGY, 2022, 96 (18)
[4]   A multivalent nucleoside-modified mRNA vaccine against all known influenza virus subtypes [J].
Arevalo, Claudia P. ;
Bolton, Marcus J. ;
Le Sage, Valerie ;
Ye, Naiqing ;
Furey, Colleen ;
Muramatsu, Hiromi ;
Alameh, Mohamad-Gabriel ;
Pardi, Norbert ;
Drapeau, Elizabeth M. ;
Parkhouse, Kaela ;
Garretson, Tyler ;
Morris, Jeffrey S. ;
Moncla, Louise H. ;
Tam, Ying K. ;
Fan, Steven H. Y. ;
Lakdawala, Seema S. ;
Weissman, Drew ;
Hensley, Scott E. .
SCIENCE, 2022, 378 (6622) :899-904
[5]   Safety and Immunogenicity of an mRNA-Based Human Metapneumovirus and Parainfluenza Virus Type 3 Combined Vaccine in Healthy Adults [J].
August, Allison ;
Shaw, Christine A. ;
Lee, Heather ;
Knightly, Conor ;
Kalidindia, Shiva ;
Chu, Laurence ;
Essink, Brandon J. ;
Seger, William ;
Zaks, Tal ;
Smolenov, Igor ;
Panther, Lori .
OPEN FORUM INFECTIOUS DISEASES, 2022, 9 (07)
[6]   Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine [J].
Baden, Lindsey R. ;
El Sahly, Hana M. ;
Essink, Brandon ;
Kotloff, Karen ;
Frey, Sharon ;
Novak, Rick ;
Diemert, David ;
Spector, Stephen A. ;
Rouphael, Nadine ;
Creech, C. Buddy ;
McGettigan, John ;
Khetan, Shishir ;
Segall, Nathan ;
Solis, Joel ;
Brosz, Adam ;
Fierro, Carlos ;
Schwartz, Howard ;
Neuzil, Kathleen ;
Corey, Larry ;
Gilbert, Peter ;
Janes, Holly ;
Follmann, Dean ;
Marovich, Mary ;
Mascola, John ;
Polakowski, Laura ;
Ledgerwood, Julie ;
Graham, Barney S. ;
Bennett, Hamilton ;
Pajon, Rolando ;
Knightly, Conor ;
Leav, Brett ;
Deng, Weiping ;
Zhou, Honghong ;
Han, Shu ;
Ivarsson, Melanie ;
Miller, Jacqueline ;
Zaks, Tal .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (05) :403-416
[7]   An overview of the vaccine platforms to combat COVID-19 with a focus on the subunit vaccines [J].
Bayani, Fatemeh ;
Hashkavaei, Negin Safaei ;
Arjmand, Sareh ;
Rezaei, Shokouh ;
Uskokovic, Vuk ;
Alijanianzadeh, Mahdi ;
Uversky, Vladimir N. ;
Siadat, Seyed Omid Ranaei ;
Mozaffari-Jovin, Sina ;
Sefidbakht, Yahya .
PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY, 2023, 178 :32-49
[8]   Recombinant protein subunit vaccine synthesis in microbes: a role for yeast? [J].
Bill, Roslyn M. .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2015, 67 (03) :319-328
[9]   Influenza Virus-like Particle-Based Hybrid Vaccine Containing RBD Induces Immunity against Influenza and SARS-CoV-2 Viruses [J].
Bommireddy, Ramireddy ;
Stone, Shannon ;
Bhatnagar, Noopur ;
Kumari, Pratima ;
Munoz, Luis E. ;
Oh, Judy ;
Kim, Ki-Hye ;
Berry, Jameson T. L. ;
Jacobsen, Kristen M. ;
Jaafar, Lahcen ;
Naing, Swe-Htet ;
Blackerby, Allison N. ;
Van der Gaag, Tori ;
Wright, Chloe N. ;
Lai, Lilin ;
Pack, Christopher D. ;
Ramachandiran, Sampath ;
Suthar, Mehul S. ;
Kang, Sang-Moo ;
Kumar, Mukesh ;
Reddy, Shaker J. C. ;
Selvaraj, Periasamy .
VACCINES, 2022, 10 (06)
[10]   Protective antibodies against human parainfluenza virus type 3 infection [J].
Boonyaratanakornkit, Jim ;
Singh, Suruchi ;
Weidle, Connor ;
Rodarte, Justas ;
Bakthavatsalam, Ramasamy ;
Perkins, Jonathan ;
Stewart-Jones, Guillaume B. E. ;
Kwong, Peter D. ;
McGuire, Andrew T. ;
Pancera, Marie ;
Taylor, Justin J. .
MABS, 2021, 13 (01)